Consistent with this notion, previous studies have demonstrated that hepcidin expression is upregulated in several types of cancer, including breast cancer, renal cell carcinoma (RCC), pancreatic cancer, prostate cancer, and colorectal cancer (23). This evidence concerns the gene HAMP and colorectal cancer.